Application for the Pharmacology Research Associate Program

Forms and Documents

Document	Type	Status	Availability
Form 1 Applicants	Form and Instruction	Modified	Repair queued
Form 1 Referees	Form and Instruction	Modified	Repair queued
ATTACHMENT 6_Dear Evaluator Letter.docx	Supplementary Document	Uploaded 2010-08-02	Repair queued
ATTACHMENT 3_Applicant Introductory Letter.docx	Supplementary Document	Uploaded 2010-08-02	Available
ATTACHMENT 2_PRAT Fact Sheet.docx	Supplementary Document	Uploaded 2010-08-02	Available
ATTACHMENT 1_PRAT Program Overview.docx	Supplementary Document	Uploaded 2010-08-02	Available
ATTACHMENT 8_Privacy Act SORN 09-25-0124.docx	Supplementary Document	Uploaded 2010-08-02	Available
ATTACHMENT 9_Privacy Act Notification Statement.pdf	Supplementary Document	Uploaded 2010-08-02	Available
A_Supporting Statement A_NIGMS PRAT Program_OMB Clearance_July_19_2010_2 (3).docx	Supporting Statement A	Uploaded 2010-08-02	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
7291	Applicants	Form and Instruction	Modified
182094	Referees	Form and Instruction	Modified

ICR Details

OMB Control No: 0925-0378	ICR Reference No: 201008-0925-002
Status: Historical Active	Previous ICR Reference No: 200709-0925-001
Agency/Subagency: HHS/NIH	Agency Tracking No:
Title: Application for the Pharmacology Research Associate Program
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/16/2010
	Date Received in OIRA: 08/17/2010
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2013	36 Months From Approved	12/31/2010
Responses	100	0	100
Time Burden (Hours)	331	0	331
Cost Burden (Dollars)	0	0	0

---

Abstract: The Pharmacology Research Associate (PRAT) Program will use the applicant and referee information to award opportunities for training and experience in laboratory or clinical investigation to individuals with a Ph.D. degree in pharmacology or a related science, M.D. or other professional degree through appointments as PRAT Fellows at the National Institutes of Health or the Food and Drug Administration. The goal of the program is to develop leaders in pharmacological research for key positions in academic, industrial, and Federal research laboratories.

---

Authorizing Statute(s): US Code: 42 USC 209(g) Name of Law: Public Health Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 27789	05/18/2010
30-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 44266	07/28/2010
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
Applicants	1, 2, 3	Verification Form ,   Associate Program ,   Evaluation Form
Referees	1, 2, 3	form ,   form ,   form

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	100	100	0	0	0	0
Annual Time Burden (Hours)	331	331	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $30,650

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/17/2010

---